Cargando…

Selective sigma-2 ligands preferentially bind to pancreatic adenocarcinomas: applications in diagnostic imaging and therapy

BACKGROUND: Resistance to modern adjuvant treatment is in part due to the failure of programmed cell death. Therefore the molecules that execute the apoptotic program are potential targets for the development of anti-cancer therapeutics. The sigma-2 receptor has been found to be over-expressed in so...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kashiwagi, Hiroyuki, McDunn, Jonathan E, Simon, Peter O, Goedegebuure, Peter S, Xu, Jinbin, Jones, Lynne, Chang, Katherine, Johnston, Fabian, Trinkaus, Kathryn, Hotchkiss, Richard S, Mach, Robert H, Hawkins, William G
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1939854/ https://www.ncbi.nlm.nih.gov/pubmed/17631687 http://dx.doi.org/10.1186/1476-4598-6-48

Ejemplares similares

Sigma-2 receptor ligands potentiate conventional chemotherapies and improve survival in models of pancreatic adenocarcinoma
por: Kashiwagi, Hiroyuki, et al.
Publicado: (2009)

Sigma-2 receptor ligand as a novel method for delivering a SMAC mimetic drug for treating ovarian cancer
por: Zeng, C, et al.
Publicado: (2013)

The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine
por: Hornick, John R, et al.
Publicado: (2010)

Lysosomal Membrane Permeabilization is an Early Event in Sigma-2 Receptor Ligand Mediated Cell Death in Pancreatic Cancer
por: Hornick, John R, et al.
Publicado: (2012)

Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site
por: Xu, Jinbin, et al.
Publicado: (2011)

Sigma-2 ligands induce tumour cell death by multiple signalling pathways
por: Zeng, C, et al.
Publicado: (2012)

Conjugation to the sigma-2 ligand SV119 overcomes uptake blockade and converts dm-Erastin into a potent pancreatic cancer therapeutic
por: Ohman, Kerri A., et al.
Publicado: (2016)

Leukocyte phenotyping to stratify septic shock patients
por: McDunn, Jonathan E, et al.
Publicado: (2009)

Quantitative Receptor-Based Imaging of Tumor Proliferation with the Sigma-2 Ligand [(18)F]ISO-1
por: Shoghi, Kooresh I., et al.
Publicado: (2013)

Conjugation to a SMAC mimetic potentiates sigma-2 ligand induced tumor cell death in ovarian cancer
por: Garg, Gunjal, et al.
Publicado: (2014)

TMEM97 and PGRMC1 do not mediate sigma-2 ligand-induced cell death
por: Zeng, Chenbo, et al.
Publicado: (2019)

Defining the ligand-dependent proximatome of the sigma 1 receptor
por: Zhao, Jing, et al.
Publicado: (2023)

The Oligomeric States of the Purified Sigma-1 Receptor Are Stabilized by Ligands
por: Gromek, Katarzyna A., et al.
Publicado: (2014)

Resorufin analogs preferentially bind cerebrovascular amyloid: potential use as imaging ligands for cerebral amyloid angiopathy
por: Han, Byung Hee, et al.
Publicado: (2011)

Sigma-2 Receptor Ligand Binding Modulates Association between TSPO and TMEM97
por: Thejer, Bashar M., et al.
Publicado: (2023)

Preferentially expressed genes in stomach adenocarcinoma cells.
por: Shiosaka, T., et al.
Publicado: (1987)

The Targeted SMAC Mimetic SW IV-134 is a strong enhancer of standard chemotherapy in pancreatic cancer
por: Hashim, Yassar M., et al.
Publicado: (2017)

Pharmacology and Therapeutic Potential of Sigma(1) Receptor Ligands
por: Cobos, E.J, et al.
Publicado: (2008)

Sigma-2 receptor ligands QSAR model dataset
por: Rescifina, Antonio, et al.
Publicado: (2017)

Sepsis Induces Extensive Autophagic Vacuolization in Hepatocytes –a clinical and laboratory based study
por: Watanabe, Eizo, et al.
Publicado: (2009)

Protein level identification of the Listeria monocytogenes Sigma H, Sigma L, and Sigma C regulons
por: Mujahid, Sana, et al.
Publicado: (2013)

DNA methyltransferase 3b preferentially associates with condensed chromatin
por: Kashiwagi, Katsunobu, et al.
Publicado: (2011)

Sigma Receptor (σR) Ligands with Antiproliferative and Anticancer Activity
por: Georgiadis, Markos-Orestis, et al.
Publicado: (2017)

Repurposing Sigma-1 Receptor Ligands for COVID-19 Therapy?
por: Vela, José Miguel
Publicado: (2020)

Effects of Sigma-1 Receptor Ligands on Peripheral Nerve Regeneration
por: Cottilli, Patrick, et al.
Publicado: (2022)

Synthesis, Computational Insights, and Evaluation of Novel Sigma Receptors Ligands
por: Dichiara, Maria, et al.
Publicado: (2023)

High energy cosmic rays
por: Langeveld, W, et al.
Publicado: (2002)

4-aroylpiperidines and 4-(α-hydroxyphenyl)piperidines as selective sigma-1 receptor ligands: synthesis, preliminary pharmacological evaluation and computational studies
por: Ikome, Hermia N., et al.
Publicado: (2016)

Preferential binding of a G-quadruplex ligand to human chromosome ends
por: Granotier, Christine, et al.
Publicado: (2005)

What is Six Sigma? /
por: Pande, Peter S.
Publicado: (2002)

Cytotoxicity Profiles and Neuroprotective Properties of the Novel Ifenprodil Analogues as Sigma Ligands
por: Zampieri, Daniele, et al.
Publicado: (2023)

Sigma-1 and Sigma-2 receptor ligands induce apoptosis and autophagy but have opposite effect on cell proliferation in uveal melanoma
por: Longhitano, Lucia, et al.
Publicado: (2017)

Hazards of Using Masking Protocols When Performing Ligand Binding Assays: Lessons From the Sigma-1 and Sigma-2 Receptors
por: Abbas, Haider, et al.
Publicado: (2020)

Preferential Cochleotoxicity of Cisplatin
por: Prayuenyong, Pattarawadee, et al.
Publicado: (2021)

A study of the reactions $\pi^{+}p \to K^{+}\Sigma^{+}$ and $K^{-}p \to \pi^{-}\Sigma^{+}$ at 10 GeV/c
por: Berglund, A, et al.
Publicado: (1975)

Lithocholic Acid Is a Vitamin D Receptor Ligand That Acts Preferentially in the Ileum
por: Ishizawa, Michiyasu, et al.
Publicado: (2018)

Identification of Metabolites in the Normal Ovary and Their Transformation in Primary and Metastatic Ovarian Cancer
por: Fong, Miranda Y., et al.
Publicado: (2011)

Morphing of Ibogaine: A Successful Attempt into the Search for Sigma-2 Receptor Ligands
por: Floresta, Giuseppe, et al.
Publicado: (2019)

Sigma-1 Receptor Modulation by Ligands Coordinates Cancer Cell Energy Metabolism
por: Oflaz, Furkan E., et al.
Publicado: (2022)

Discovery of AD258 as a Sigma Receptor Ligand with Potent Antiallodynic Activity
por: Dichiara, Maria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_57hg93tbc1i8vjgrfavsa8bjnk